coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Gorton And Levenshulme PCN, Manchester (LAD) · Health Inequalities Profile

    PCN U34667 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    56,659

    Registered population

    65.3% aged 18–64

    9.4%

    Aged 65+

    ICB 14.9% · England 17.9%

    58.6%

    Ethnic minority (non-White)

    38.7% Asian · England 9.6%

    86.1%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~46,073

    Core20 residents (est.)

    Resident basis; registered basis ~48,101 · see page 3

    7,321

    Hypertension register

    +4.90% in 3 yrs · England +5.60%

    758

    SMI register

    8% of Manchester (LAD)'s

    1,238

    COPD register

    Reviews +11.32% in 3 yrs

    Forecast to 2030

    8,470

    Hypertension patients, 2030

    +1,149 on today

    79.6%

    QRISK ≥20% on statins, 2030

    +2.16pp over 3 yrs

    2.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    75.1%
    Lipid therapy reach exceeds national and local benchmarks.

    Lipid-lowering therapy for QRISK ≥ 20% reaches 75.1% (England 63.6%; Manchester (LAD) 70.5%), and 79.0% in CKD (England 70.3%).

    -13.6%
    Learning disability and COPD registers fell over three.

    Three-year QOF prevalence fell 13.6% in learning disability (England +5.4%) and 4.0% in COPD (England +2.6%), which may reflect coding gaps to audit.

    53.8%
    Screening and pre-school booster uptake lag national benchmarks.

    Breast screening is 53.8% (England 69.9%, despite +23.0% three-year growth) and age-5 4-in-1 coverage is 80.7%, below the 95.0% target by 14.3 pp.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Population, age and ethnicity

    Census estimates show Asian / Asian British residents comprise 38.7% at PCN level, compared to 20.9% in Manchester (LAD), 13.6% in NHS Greater Manchester Integrated Care Board, and 9.6% in England. This Census measure reflects resident demographics rather than registered patient ethnicity; compare with GP records before assessing service reach.

    Age profile

    0–1725.3%
    18–6465.3%
    65+9.4%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White41.4%
    Asian38.7%
    Black11.9%
    Other4.1%
    Mixed3.9%

    Older people · falls rows are Manchester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Manchester LA)2,3572,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.5%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Manchester LA)1,2811,0219552024/25
    Falls deaths, all ages, per 100,000 (Manchester LA)26.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 86.1% of the list, spanning 60.8 pp between practices

    The PCN average IMD decile is 1.8 (Manchester (LAD) 3.0 decile; NHS Greater Manchester Integrated Care Board 4.5 decile; England 5.5 decile), with 86.1% of registered patients living in Core20 areas (Manchester (LAD) 59.8%; NHS Greater Manchester Integrated Care Board 40.7%; England 21.0%). Weighted practice share is 84.9% (a 1.17 percentage points discrepancy). Across practices, the Core20 share range is 60.8 pp. Hawthorn MC records 39.2%, while Gorton Medical Centre, Mount Road Surgery, and West Gorton Medical Practice each record 100.0%.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Gorton100.0% · 10,684 patients
    Mount Road100.0% · 7,726 patients
    West Gorton100.0% · 7,693 patients
    Levenshulme89.1% · 7,997 patients
    Ashcroft87.8% · 6,481 patients
    West Point63.1% · 5,154 patients
    Hawthorn MC39.2% · 2,366 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    758

    SMI register

    1.30% recorded prevalence

    460

    Learning disability register

    0.79% recorded prevalence

    10

    Care homes, 282 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Manchester (LAD), Census 2021

    Severe mental illness register (patients) is 758 at PCN level. No comparative benchmark was captured for this register count, so it provides baseline volume context only.

    Severe mental illness: physical health checks

    Severe mental illness QOF prevalence is 1.3% (758 patients). In the last 12 months, 82.4% had a blood pressure check (England 83.4%) and 81.2% had BMI recorded (England 82.1%). Other health check elements were not captured.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,321

    Hypertension register

    +4.90%

    Register growth, 3 yrs

    Manchester (LAD) +4.49% · England +5.60%

    +6.48pp

    BP control, under 80

    ≤140/90 · +3.98pp aged 80+

    +1,149

    More patients by 2030

    Forecast 8,470 (13.86%)

    Hypertension case-finding and control

    Hypertension recorded QOF prevalence is 12.6% at PCN level, which is 2.1 percentage points above Manchester (LAD) (10.5%), but below NHS Greater Manchester Integrated Care Board (14.4%) by 1.8 percentage points and below England (15.2%) by 2.6 percentage points. Crude prevalence does not establish undiagnosed disease or case-finding quality; age-standardised comparisons would test whether differences reflect the younger population profile.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid lowering therapy is 75.1% at PCN level, exceeding England (63.6%) by 11.5 percentage points, NHS Greater Manchester Integrated Care Board (67.0%) by 8.1 percentage points, and Manchester (LAD) (70.5%) by 4.6 percentage points.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026103,313£2.00£1.94£1.86£206,626
    Cardiovascular (all), 2025124,327£2.31£3.15£3.33£287,195

    Cost per item for lipid-regulating drugs 2026 is £2.00 (England £1.86; NHS Greater Manchester Integrated Care Board £1.94; Manchester (LAD) £2.21). Across 103,313 items, annual spend is £206,626, which is £14,464 more than at England's unit cost. This unit-cost metric does not reflect treatment appropriateness or efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +12.66%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.85%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual review coverage is 65.3% (England 65.7%), following a 3-year change of +12.7% (England +4.4%), leaving about 1,200 (1,174) of 3,384 patients unreviewed. Second-hand smoking recording for patients aged 6-19 years is 81.0% (England 78.8%). COPD reviews reached 73.2% (England 76.4%) after a 3-year change of +11.3% (England +2.8%), while COPD prevalence fell 4.0% (England +2.6%). Register changes could reflect coding differences to audit locally.

    Cancer register and children's immunisation

    Cancer register prevalence is 2.2% (1,307 patients; England 3.8%). In Q1 2025/26 childhood immunisation, coverage is below the 95.0% target: 6-in-1 at 12 months is 90.1%, MMR dose 1 at 24 months is 87.2%, and age-5 4-in-1 booster is 80.7% (14.3 pp below target). MMR dose 2 at age 5 is 85.6%, 5.3 pp below dose 1 (90.9%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.1%

    England 91.0%

    6-in-1 complete primary course at 24 months90.1%

    England 92.2%

    MMR dose 1 at 24 months87.2%

    England 88.3%

    MMR dose 2 at age 585.6%

    England 82.8%

    4-in-1 pre-school booster at age 580.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage across NHS Greater Manchester ICB (6,491 of 11,679; 70.8% staged coverage) were diagnosed at stage 1 or 2, compared to 55.3% in England and 19.4 pp below the 75.0% ambition for 2028 (an ICB gap of about 2,270 cases annually; +3.1 pp since 2013). These system figures exclude unstaged cancers. Locally, PCN cervical screening is 61.7% (England 66.8%) and breast screening is 53.8% (England 69.9%). Lower primary care screening uptake could delay detection across pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For Jul 2026 (provisional), Manchester University NHS Foundation Trust achieved 72.8% on the cancer 62-day referral to treatment standard (12.2 pp below the 85.0% standard) and 80.1% on the 28-day faster diagnosis standard (exceeding the 75.0% standard). On 62-day waits, Stockport NHS Foundation Trust reached 74.7% and Tameside and Glossop Integrated Care NHS Foundation Trust reached 76.8% (ICB 75.7%; England 71.2%). On the 28-day standard, Stockport NHS Foundation Trust was 83.2% and Tameside and Glossop Integrated Care NHS Foundation Trust was 82.5% (ICB 79.5%; England 79.3%). These hospital figures reflect wider provider pressures rather than PCN performance.

    Pathways within standard (%)ManchesterStockportTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0683.2182.4879.5379.32
    31-day treatment (96%)92.5497.3996.2596.4992.50
    62-day referral to treatment (85%)72.8574.6776.7775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterStockportTameside and Glossop Integrated CareEngland
    MRI11.681.410.0021.40
    CT14.662.930.189.92
    Echocardiography4.9117.460.0028.48
    Colonoscopy4.515.531.5130.83
    Gastroscopy29.355.315.4529.02
    All 15 DM01 tests8.9814.080.8023.14
    Community services activityManchester residentsGreater Manchester ICB
    Care contacts96,995573,310
    Referrals20,27094,470
    Patients with a contact31,040183,535

    Community services (residents of Manchester), Jun 2026 (provisional). In provisional community services data for Jun 2026, 43.3% of community contacts among Manchester borough residents were with adults aged 65 and over (42,015 of 96,995 total contacts). This activity captures borough residents rather than PCN-registered patients, reflecting substantial older-age community health service demand across the local authority area.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination and immunisation achievement varies by 84.4 pp across PCN practices

    In 2025/26, clinical QOF achievement reached 100.0% at Mount Road Surgery. However, vaccination and immunisation domain achievement varied by 84.4 pp, from 15.6% at Gorton Medical Centre to 100.0% at Levenshulme Medical Practice, against 55.2% for England. High clinical domain achievement can coexist with wide variation in points awarded for immunisation.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ashcroft Surgery11487.860.6%69.7%91.1%
    West Point10263.170.7%82.9%83.0%
    West Gorton90100.047.6%75.5%78.2%
    Levenshulme9889.152.2%80.1%77.7%
    Mount Road Surgery115100.066.8%70.1%72.1%
    Gorton92100.055.1%65.9%70.3%
    Hawthorn MC8739.254.9%79.2%68.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNManchester (LAD)AssetPCNManchester (LAD)
    Care homes (catchment)10 (282 beds)n/aSchools (catchment)76n/a
    Children's centres534Places of worship50289
    Libraries416Homelessness support (VCS)11
    Primary schools (LA maintained)1168Primary academies750
    Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Standardised asthma annual review recall

    Asthma review coverage is 65.3% (0.4 pp below England at 65.7% and 1.7 pp below Manchester (LAD) at 67.0%, despite +12.7% 3-year growth), leaving about 1,200 (1,174) of 3,384 asthma patients unreviewed. For discussion: run a single-template asthma review recall with after-school or holiday slots and inhaler checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Dementia case-finding and coding review

    Recorded dementia QOF prevalence is 0.3% (170 patients vs 0.4% Manchester (LAD) and 0.8% England), giving an unadjusted benchmark scenario range of +55 to +273 patients. For discussion: search practice records for cognitive concern codes or dementia medicines without a register code. Moderate effort to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Differentiated Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Audit full SMI checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Preschool booster recall catchup (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Standardised asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Dementia case-finding and coding review (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15